WeVote
Log In

Bill

Bill

HB 4417

Health occupations: emergency medical services personnel; access to opioid antagonists; provide to life support agencies under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 20911.

2025-2026 Regular Session Introduced by Mike Mueller

Requires DHHS to provide opioid antagonists (e.g., naloxone) at no cost to life support agencies when distributing free doses for overdoses.

REFERRED TO COMMITTEE ON HEALTH POLICY
#controlledsubstances:opioids #healthoccupations:emergencymedicalservicespersonnel #health:pharmaceuticals #stateagencies(existing):healthandhumanservices
0
WeVote Research Nonpartisan
Bill Summary · HB 4417

Summary — HB 4417 (2025): Opioid antagonists — provision to life support agencies

Sponsor: Rep. Mike Mueller
Action: Amends the Michigan Public Health Code (1978 PA 368) by adding MCL 333.20911
Status: Passed House (June 26, 2025); referred to Senate Committee on Health Policy (July 1, 2025)
Filed: March 11, 2025; introduced May 1, 2025

Purpose / intent

Require the Michigan Department of Health and Human Services (DHHS) to provide opioid antagonists (e.g., naloxone) free of charge directly to life support agencies for equipping life support vehicles whenever DHHS is distributing opioid antagonists at no cost to others in the state. The goal is to expand access to lifesaving overdose reversal drugs in the prehospital/emergency services setting.

Key provisions

  • Adds section 20911 to the Public Health Code (MCL 333.20911).
  • Triggers requirement: if DHHS distributes an opioid antagonist at no cost to a person to reduce opioid-related overdoses, DHHS must, upon request and at no cost, provide an opioid antagonist directly to a "life support agency" for the purpose of equipping a life support vehicle described in MCL 333.20919(1)(k).
  • Defines "opioid antagonist" to mean naloxone hydrochloride or any similarly acting and equally safe FDA‑approved drug for treating drug overdose.
  • "Life support agency" refers to entities licensed under Part 209 (Emergency Medical Services) — e.g., ambulance operations, nontransport prehospital life support, aircraft transport, or medical first response services.

Who would be affected

  • DHHS: responsible for supplying kits to requesting life support agencies when DHHS is otherwise distributing free opioid antagonists.
  • Life support agencies and their life support vehicles (ambulances, EMS units, medical first responders) — they may request free opioid antagonist kits.
  • Local governments: no direct fiscal impact expected on local units per analysis.

Fiscal and operational impact

  • State expenditures to DHHS would increase by an indeterminate amount, depending on demand and procurement costs.
  • Historical DHHS distribution: 25,872 kits to local health departments and 252,180 kits to other agencies; current price cited ≈ $29 per kit (~$14.50 per dose).
  • The bill does not change existing clinical guidance or EMS licensing rules beyond supply obligations.

Background

  • Naloxone rapidly reverses opioid overdose and is available OTC; common brands include Narcan and Evzio.
  • Michigan overdose deaths: 2,998 (2022) and 2,931 (2023); estimated ~80% were opioid-related. National opioid overdose deaths were 81,083 in 2023.
  • Supporters testified the bill helps ensure fire departments and other first responders have access to naloxone.

Procedural timeline (selected)

  • Filed: 2025-03-11; introduced: 2025-05-01.
  • Committee activity: public hearing and report without amendment (Regulatory Reform).
  • Passed House: June 26, 2025 (Roll Call #166 — Yeas 100, Nays 4); given immediate effect; transmitted to Senate and referred to Committee on Health Policy (July 1, 2025).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.